Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice

American Journal of Transplantation

Volumn 12, Issue 2, 2012, Pages 322-329

  McCall, M ^a   Pawlick, R ^a   Kin, T ^a   Shapiro, A M J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anakinra; engraftment; etanercept; islet transplantation

Indexed keywords

ETANERCEPT; INSULIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DRUG POTENTIATION; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; METABOLISM; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 84856473153     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03796.x     Document Type: Article

References (51)

1. The Collaborative Islet Transplant Registry 2009 Annual Report. wwwcitregistryorg/reports/reportshtm.
2. Farney AC, Xenos E, Sutherland DE, et al,. Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant Proc 1993; 25 (Pt 2): 865-866. (Pubitemid 23078813)
3. Hering BJ, Kandaswamy R, Ansite JD, et al,. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835. (Pubitemid 40250366)
4. Shapiro AM, Ricordi C,. Unraveling the secrets of single donor success in islet transplantation. Am J Transplant 2004; 4: 295-298. (Pubitemid 38282283)
5. Matsumoto S, Takita M, Chaussabel D, et al,. Improving efficacy of clinical islet transplantation with iodixanol based islet purification, thymoglobulin induction and blockage of IL-1-beta and TNF-alpha. Cell Transplant 2011. 2011 Mar 8. [Epub ahead of print]. PMID: 21396171.
6. Wang T, Singh B, Warnock GL, Rajotte RV,. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 1992; 41: 114-117.
7. Kin T, Senior P, O'Gorman D, Richer B, Salam A, Shapiro AM,. Risk factors for islet loss during culture prior to transplantation. Transplant Int 2008; 21: 1029-1035.
8. Ricordi C, Lacy PE, Scharp DW,. Automated islet isolation from human pancreas. Diabetes 1989; 38 (Suppl 1): 140-142. (Pubitemid 19029262)
9. Barbaro B, Salehi P, Wang Y, et al,. Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation 2007; 84: 1200-1203. (Pubitemid 350125364)
10. Toso C, McCall M, Emamaullee J, et al,. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transplant Int 2010; 23: 259-265.
11. Gangemi A, Salehi P, Hatipoglu B, et al,. Islet transplantation for brittle type 1 diabetes: The UIC protocol. Am J Transplant 2008; 8: 1250-1261. (Pubitemid 351763686)
12. Ricordi C, Gray DW, Hering BJ, et al,. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185-195. (Pubitemid 20367488)
13. Barnett MJ, McGhee-Wilson D, Shapiro AM, Lakey JR,. Variation in human islet viability based on different membrane integrity stains. Cell Transplant 2004; 13: 481-488. (Pubitemid 39557427)
14. Weinblatt ME, Kremer JM, Bankhurst AD, et al,. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-259. (Pubitemid 29063266)
15. Moreland LW, Schiff MH, Baumgartner SW, et al,. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999; 130: 478-486. (Pubitemid 29135800)
16. Cohen SB, Moreland LW, Cush JJ, et al,. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 2004; 63: 1062-1068. (Pubitemid 39120355)
17. Bellin MD, Kandaswamy R, Parkey J, et al,. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008; 8: 2463-2470.
18. Froud T, Ricordi C, Baidal DA, et al,. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046. (Pubitemid 41039883)
19. Mertens M, Singh JA,. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev 2009: CD005121.
20. Larsen CM, Faulenbach M, Vaag A, et al,. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526. (Pubitemid 46588416)
21. Health, Canada. Use of Keneret (anakinra) in Combination wioth etanercept. 2002.
22. Genovese MC, Cohen S, Moreland L, et al,. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 2004; 50: 1412-1419. (Pubitemid 38608062)
23. Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I,. Cytotoxic effects of cytokines on rat islets: Evidence for involvement of free radicals and lipid peroxidation. Diabetologia 1992; 35: 409-413.
24. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M,. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232 (4757): 1545-1547. (Pubitemid 16061563)
25. Darville MI, Eizirik DL,. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 1998; 41: 1101-1108. (Pubitemid 28394417)
26. Montolio M, Biarnes M, Tellez N, Escoriza J, Soler J, Montanya E,. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. J Endocrinol 2007; 192: 169-177. (Pubitemid 46444407)
27. Suarez-Pinzon WL, Strynadka K, Rabinovitch A,. Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes. Endocrinology 1996; 137: 5290-5296. (Pubitemid 26423087)
28. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV,. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab 1996; 81: 3197-3202. (Pubitemid 26296188)
29. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW,. Beta cell apoptosis in diabetes. Apoptosis 2009; 14: 1389-1404.
30. Grilli M, Chiu JJ, Lenardo MJ,. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1-62. (Pubitemid 23166972)
31. Stassi G, De Maria R, Trucco G, et al,. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 1997; 186: 1193-1200. (Pubitemid 27469014)
32. Barshes NR, Wyllie S, Goss JA,. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587-597. (Pubitemid 40628740)
33. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E,. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51: 66-72. (Pubitemid 34517981)
34. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC,. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161-1167. (Pubitemid 26296313)
35. Carpenter L, Cordery D, Biden TJ,. Protein kinase Cdelta activation by interleukin-1beta stabilizes inducible nitric-oxide synthase mRNA in pancreatic beta-cells. J Biol Chem 2001; 276: 5368-5374.
36. Carpenter L, Cordery D, Biden TJ,. Inhibition of protein kinase C delta protects rat INS-1 cells against interleukin-1beta and streptozotocin-induced apoptosis. Diabetes 2002; 51: 317-324. (Pubitemid 34764786)
37. Stassi G, Todaro M, Richiusa P, et al,. Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 1995; 27: 3271-3275. (Pubitemid 26016176)
38. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T,. Inflammatory mediators and islet beta-cell failure: A link between type 1 and type 2 diabetes. J Mol Med 2003; 81: 455-470. (Pubitemid 37070198)
39. Rath PC, Aggarwal BB,. TNF-induced signaling in apoptosis. J Clin Immunol 1999; 19: 350-364. (Pubitemid 30039103)
40. Andersen NA, Larsen CM, Mandrup-Poulsen T,. TNFalpha and IFNgamma potentiate IL-1beta induced mitogen activated protein kinase activity in rat pancreatic islets of Langerhans. Diabetologia 2000; 43: 1389-1396.
41. Giannoukakis N, Rudert WA, Ghivizzani SC, et al,. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999; 48: 1730-1736. (Pubitemid 29415190)
42. Piemonti L, Leone BE, Nano R, et al,. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 2002; 51: 55-65. (Pubitemid 34517980)
43. Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AM,. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002; 73: 1106-1110. (Pubitemid 34415443)
44. Lakey JR, Warnock GL, Rajotte RV, et al,. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047-1053. (Pubitemid 26120253)
45. Kin T, Zhai X, Murdoch TB, Salam A, Shapiro AM, Lakey JR,. Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant 2007; 7: 1233-1241. (Pubitemid 46643110)
46. Lakey JR, Rajotte RV, Warnock GL, Kneteman NM,. Cold ischemic tolerance of human pancreas: Assessment of islet recovery and in vitro function. Transplant Proc 1994; 26: 3416.
47. Kneteman NM, Lakey JR, Kizilisik TA, Ao Z, Warnock GL, Rajotte RV,. Cadaver pancreas recovery technique. Impact on islet recovery and in vitro function. Transplantation 1994; 58: 1114-1119. (Pubitemid 24377931)
48. Pileggi A, Ribeiro MM, Hogan AR, et al,. Effects of pancreas cold ischemia on islet function and quality. Transplant Proc 2009; 41: 1808-1809.
49. Froud T, Ricordi C, Baidal DA, et al,. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046. (Pubitemid 41039883)
50. Han D, Xu X, Baidal D, et al,. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: Elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 2281-2290. (Pubitemid 39145581)
51. Kenyon NS, Ricordi C,. Pretransplant immune parameters associate with islet allograft outcome: Implications for transplant strategy? Diabetes 2009; 58: 2187-2188.